Compounded medications allow for more flexible dosing schedules and lower starting doses, which some patients tolerate better
As of 2024, the FDA approved the medication Rezdiffra (resmetirom) for the treatment of nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis
The process is the same regardless of starting dose, reduce by 2.5 mg every 4 to 8 weeks until you reach 2.5 mg, then discontinue
Clinics offering FDA-approved brands or oral options are better aligned with that preference
ESR study of the erythrocyte membrane skeletal protein network: influence of the state of aggregation of spectrin on the physical state of membrane proteins, bilayer lipids, and cell surface carbohydrates Biochim Biophys Acta 1985
For brands and retailers, the message is clear: we are moving from raw-material competition to performance-driven delivery